Literature DB >> 33663136

Effectiveness of acupuncture for anxiety and depression in irritable bowel syndrome: A protocol for systematic review and meta-analysis.

Huaiyu Li1, Yun Chen2, Ziyi Hu3, Jiawang Jiang1, Jing Ye1, Yuliang Zhou1, Zhiying Yu1, Haiyi Tang1.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is the most commonly gastrointestinal diseases. The Rome Foundation's global study on 33 countries shows the total prevalence of IBS under the Rome IV Diagnostic Criteria was 3.8%. It is well established that people with IBS have higher levels of anxiety and depression. The impact of the acupuncture associated with anxiety and depression has been widely studied in Western countries. Acupuncture may be a promising choice for the treatment of anxiety and depression in IBS.
METHODS: RCTs of acupuncture for depression and anxiety in IBS will be searched in the relevant database, including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Biomedical Literature Database (CBM), and Chinese Scientific Journal Database (VIP database). The studies of electronic searches will be exported to EndNote V.9.1 software. We will run meta-analyses using the Review Manager (RevMan) V.5.3 software. Any disagreement will be solved in consultation with a third reviewer.
RESULTS: Our study aims to explore the efficacy of acupuncture for depression and anxiety in IBS and to provide up-to-date evidence for clinical of IBS.
CONCLUSION: This study will perform a comprehensive systematic review and meta-analysis on the efficacy of acupuncture for depression and anxiety in IBS, making up for the lack of relevant evidence of the clinical use of acupuncture. INPLASY REGISTRATION NUMBER: INPLASY 202120014.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33663136      PMCID: PMC7909111          DOI: 10.1097/MD.0000000000024958

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  27 in total

Review 1.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  Rona L Levy; Kevin W Olden; Bruce D Naliboff; Laurence A Bradley; Carlos Francisconi; Douglas A Drossman; Francis Creed
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome.

Authors:  Mohammad Zamani; Shaghayegh Alizadeh-Tabari; Vahid Zamani
Journal:  Aliment Pharmacol Ther       Date:  2019-06-03       Impact factor: 8.171

Review 3.  The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment.

Authors:  David J Gracie; P John Hamlin; Alexander C Ford
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-05-20

Review 4.  Irritable bowel syndrome: a gut microbiota-related disorder?

Authors:  Yogesh Bhattarai; David A Muniz Pedrogo; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

5.  The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).

Authors:  N Kanuri; B Cassell; S E Bruce; K S White; B M Gott; C P Gyawali; G S Sayuk
Journal:  Neurogastroenterol Motil       Date:  2016-05-05       Impact factor: 3.598

Review 6.  Irritable bowel syndrome: a clinical review.

Authors:  William D Chey; Jacob Kurlander; Shanti Eswaran
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

7.  Anxiety, depression and quality of life in patients with irritable bowel syndrome.

Authors:  Hyun Sun Cho; Jae Myung Park; Chul Hyun Lim; Yu Kyung Cho; In Seok Lee; Sang Woo Kim; Myung-Gyu Choi; In-Sik Chung; Yun Kyung Chung
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

Review 8.  Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome.

Authors:  B Spiegel; P Schoenfeld; B Naliboff
Journal:  Aliment Pharmacol Ther       Date:  2007-07-15       Impact factor: 8.171

9.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

Review 10.  The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.

Authors:  Changhyun Lee; Eunyoung Doo; Ji Min Choi; Seung-Ho Jang; Han-Seung Ryu; Ju Yup Lee; Jung Hwan Oh; Jung Ho Park; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.